These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3806602)

  • 1. Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications.
    Ross ST; Franz RG; Gallagher G; Brenner M; Wilson JW; DeMarinis RM; Hieble JP; Sarau HM
    J Med Chem; 1987 Jan; 30(1):35-40. PubMed ID: 3806602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines.
    Ross ST; Franz RG; Wilson JW; Brenner M; DeMarinis RM; Hieble JP; Sarau HM
    J Med Chem; 1986 May; 29(5):733-40. PubMed ID: 2871192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
    Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
    J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
    J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL; Wilson JW; Hieble JP
    J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
    Baindur N; Tran M; Niznik HB; Guan HC; Seeman P; Neumeyer JL
    J Med Chem; 1992 Jan; 35(1):67-72. PubMed ID: 1531075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Abbracchio MP; Paoletti AM; Balduini W
    J Med Chem; 1992 Nov; 35(23):4408-14. PubMed ID: 1360027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
    Ryman-Rasmussen JP; Nichols DE; Mailman RB
    Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
    O'Boyle KM; Gaitanopoulos DE; Brenner M; Waddington JL
    Neuropharmacology; 1989 Apr; 28(4):401-5. PubMed ID: 2568596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
    J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dopamine- and octopamine-sensitive adenylate cyclase in the nervous system of Octopus vulgaris.
    Capasso A; Carginale V; Madonna L; Mancaniello D; Scudiero R; Paolo De Prisco P; De Petrocellis B; Parisi E
    Comp Biochem Physiol B; 1991; 100(4):805-8. PubMed ID: 1782763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.